|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 903.3 DKK | -1.05% |
|
+2.28% | +29.39% |
| May. 17 | Roche: share price stands out, Deutsche Bank in support | CF |
| May. 16 | Health Care Flat as Momentum Wanes -- Health Care Roundup | DJ |
Novo Nordisk A/S reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was DKK 65,349 million compared to DKK 53,367 million a year ago. Net income was DKK 25,407 million compared to DKK 19,814 million a year ago.
Basic earnings per share from continuing operations was DKK 5.7 compared to DKK 4.4 a year ago. Diluted earnings per share from continuing operations was DKK 5.68 compared to DKK 4.39 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +29.39% | 584B | |
| +32.09% | 693B | |
| -1.34% | 372B | |
| +20.34% | 332B | |
| +7.39% | 294B | |
| +14.25% | 239B | |
| -3.03% | 211B | |
| +10.02% | 210B | |
| +8.49% | 168B | |
| -0.52% | 162B |
NOVO NORDISK A/S 
